The American Association of Endocrine Surgeons, Patient Education Site

References: Parathyroid glands

This document is available in Spanish
  1. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341(17):1249-55.
  2. Mollerup CL, Vestergaard P, Frokjaer VG, et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 2002; 325(7368):807.
  3. Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Urol Clin North Am 2000; 27(2):275-85, viii.
  4. Giles Y, Baspinar I, Tunca F, et al. Impact of surgical treatment on respiratory muscle dysfunction in symptomatic hyperparathyroidism. Arch Surg 2005; 140(12):1167-71.
  5. Kristoffersson A, Bostrom A, Soderberg T. Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 1992; 79(2):165-8.
  6. Chou FF, Sheen-Chen SM, Leong CP. Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism. Surgery 1995; 117(1):18-25.
  7. Joborn C, Hetta J, Johansson H, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg 1988; 12(4):476-81.
  8. McAllion SJ, Paterson CR. Psychiatric morbidity in primary hyperparathyroidism. Postgrad Med J 1989; 65(767):628-631.
  9. Goyal A, Chumber S, Tandon N, et al. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J Med Sci 2001; 55(12):677-86.
  10. Roman SA, Sosa JA, Mayes L, et al. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 2005; 138(6):1121-8; discussion 1128-9..
  11. Dotzenrath CM, Kaetsch AK, Pfingsten H, et al. Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 2006; 30(5):680-5.
  12. Spivak B, Radvan M, Ohring R, Weizman A. Primary hyperparathyroidism, psychiatric manifestations, diagnosis and management. Psychother Psychosom 1989; 51(1):38-44.
  13. Perrier ND, Coker LH, Rorie KD, et al. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg 2006; 30(5):686-96.
  14. Mittendorf EA, Wefel JS, Meyers CA, et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract 2007; 13(4):338-44.
  15. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edition. San Antonio: The Psychological Corp., 1997.
  16. Okamoto T, Kamo T, Obara T. Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism. Arch Surg 2002; 137(7):779-83; discussion 784.
  17. Kleinfeld M, Peter S, Gilbert GM. Delirium as the predominant manifestation of hyperparathyroidism: reversal after parathyroidectomy. J Am Geriatr Soc 1984; 32(9):689-90.
  18. Alarcon RD, Franceschini JA. Hyperparathyroidism and paranoid psychosis. Case report and review of the literature. Br J Psychiatry 1984; 145:477-86.
  19. Borer MS, Bhanot VK. Hyperparathyroidism: neuropsychiatric manifestations. Psychosomatics 1985; 26(7):597-601.
  20. Brown RS, Jr., Fischman A, Showalter CR. Primary hyperparathyroidism, hypercalcemia, paranoid delusions, homicide, and attempted murder. J Forensic Sci 1987; 32(5):1460-1463.
  21. Hayabara T, Hashimoto K, Izumi H, et al. Neuropsychiatric disorders in primary hyperparathyroidism. Jpn J Psychiatry Neurol 1987; 41(1):33-40.
  22. Solomon BL, Schaaf M, Smallridge RC. Psychologic symptoms before and after parathyroid surgery. Am J Med 1994; 96(2):101-6.
  23. Brown GG, Preisman RC, Kleerekoper M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 1987; 35(4):211-5.
  24. Reinfrank RF. Primary hyperparathyroidism with depression. Arch Intern Med 1961; 108:606-10.
  25. Weber T, Keller M, Hense I, et al. Effect of parathyroidectomy on quality of life and neuropsychological symptoms in primary hyperparathyroidism. World J Surg 2007; 31(6):1202-9.
  26. Logue FC, Fraser WD, Gallacher SJ, et al. The loss of circadian rhythm for intact parathyroid hormone and nephrogenous cyclic AMP in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 1990; 32(4):475-83.
  27. Nilsson IL, Aberg J, Rastad J, Lind L. Circadian cardiac autonomic nerve dysfunction in primary hyperparathyroidism improves after parathyroidectomy. Surgery 2003; 134(6):1013-9; discussion 1019.
  28. Walker RP, Paloyan E, Gopalsami C. Symptoms in patients with primary hyperparathyroidism: muscle weakness or sleepiness. Endocr Pract 2004; 10(5):404-8.
  29. Perrier ND. Surgery 2009; In Press.
  30. Burney RE, Jones KR, Christy B, Thompson NW. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 1999; 125(6):608-14.
  31. Quiros RM, Alef MJ, Wilhelm SM, et al. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 2003; 134(4):675-81; discussion 681-3.
  32. Pasieka JL, Parsons LL. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 1998; 22(6):513-8; discussion 518-9.
  33. Fitz TE, Hallman BL. Mental changes associated with hyperparathyroidism; report of two cases. AMA Arch Intern Med 1952; 89(4):547-51.
  34. Agras S, Oliveau DC. Primary Hyperparathyroidism and Psychosis. Can Med Assoc J 1964; 91:1366-7.
  35. Chan AK, Duh QY, Katz MH, et al. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 1995; 222(3):402-12; discussion 412-4.
  36. Rosenblatt S, Faillace LA. Psychiatric manifestations of hyperparathyroidism. Tex Med 1977; 73(2):59-60.
  37. Talpos GB, Bone HG, 3rd, Kleerekoper M, et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 2000; 128(6):1013-20;discussion 1020-1.
  38. Vazquez-Diaz O, Castillo-Martinez L, Orea-Tejeda A, et al. Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism. Cardiol J 2009; 16(3):241-5.
  39. Leifsson BG, Ahren B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 1996; 81(6):2149-53.
  40. Hedback G, Oden A, Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 1991; 15(3):399-405; discussion 406-7.
  41. Kebebew E, Hwang J, Reiff E, et al. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 2006; 141(8):777-82; discussion 782.
  42. Harari A, Zarnegar R, Lee J, et al. Computed tomography can guide focused exploration in select patients with primary hyperparathyroidism and negative sestamibi scanning. Surgery 2008; 144(6):970-6; discussion 976-9.
  43. Vestergaard P, Mollerup CL, Frokjaer VG, et al. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000; 321(7261):598-602.
  44. VanderWalde LH, Liu IL, O'Connell TX, Haigh PI. The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch Surg 2006; 141(9):885-9; discussion 889-91.
  45. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93(9):3462-70.
  46. Corlew DS, Bryda SL, Bradley EL, 3rd, DiGirolamo M. Observations on the course of untreated primary hyperparathyroidism. Surgery 1985; 98(6):1064-71.
  47. Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2005; 90(1):135-41.
  48. Wuthrich RP, Martin D, Bilezikian JP. The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Invest 2007; 37(12):915-22.
  49. Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J Surg 1998; 22(6):531-5; discussion 535-6.
  50. Kebebew E, Duh QY, Clark OH. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg 2003; 138(8):867-71.
  51. Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 2007; 92(10):3803-8.
  52. Zanocco K, Angelos P, Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 2006; 140(6):874-81; discussion 881-2.
  53. Parfitt AM. Hormonal influences on bone remodeling and bone loss: application to the management of primary hyperparathyroidism. Ann Intern Med 1996; 125(5):413-5.
  54. Khan AA, Bilezikian JP, Kung AW, et al. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2004; 89(7):3319-25.
  55. Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ. Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 2002; 87(10):4482-9.
  56. Chow CC, Chan WB, Li JK, et al. Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88(2):581-7.
  57. Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007; 92(5):1687-92.
  58. Guo CY, Thomas WE, al-Dehaimi AW, et al. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81(10):3487-91.
  59. Diamond T, Ng AT, Levy S, et al. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos Int 1996; 6(4):329-33.
  60. Grey AB, Stapleton JP, Evans MC, et al. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med 1996; 125(5):360-8.
  61. Orr-Walker BJ, Evans MC, Clearwater JM, et al. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women. Arch Intern Med 2000; 160(14):2161-6.
  62. Sosa JA, Powe NR, Levine MA, et al. Profile of a clinical practice: Thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. J Clin Endocrinol Metab 1998; 83(8):2658-65.
  63. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 2002; 236(5):543-51.
  64. Carneiro DM, Solorzano CC, Irvin GL, 3rd. Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 2004; 199(6):849-53; discussion 853-5.
  65. Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999; 126(6):1016-21; discussion 1021-2.
  66. Barczynski M, Cichon S, Konturek A, Cichon W. Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 2006; 30(5):721-31.
  67. Miccoli P, Berti P. Minimally invasive parathyroid surgery. Best Pract Res Clin Endocrinol Metab 2001; 15(2):139-47.
  68. Irvin GL, 3rd, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 2004; 28(12):1287-92.
  69. Udelsman R, Donovan PI. Remedial parathyroid surgery: changing trends in 130 consecutive cases. Ann Surg 2006; 244(3):471-9.
  70. Wu BH, PI; Bath, J. Utilization of parathyroidectomy in older patients: a population-based study., 2009.
  71. Flint RS, Harman CR, Carter J, Snyman G. Primary hyperparathyroidism: referral patterns and outcomes of surgery. ANZ J Surg 2002; 72(3):200-3.
  72. Bachar G, Gilat H, Mizrachi A, et al. Comparison of perioperative management and outcome of parathyroidectomy between older and younger patients. Head Neck 2008; 30(11):1415-21.
  73. Chigot JP, Menegaux F, Achrafi H. Should primary hyperparathyroidism be treated surgically in elderly patients older than 75 years? Surgery 1995; 117(4):397-401.
  74. Egan KR, Adler JT, Olson JE, Chen H. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res 2007; 140(2):194-8.
  75. Mannix H, Jr., Pyrtek LJ, Crombie HD, Jr., Canalis E. Hyperparathyroidism in the elderly. Am J Surg 1980; 139(4):581-5.
  76. Pruhs ZM, Starling JR, Mack E, Chen H. Changing trends for surgery in elderly patients with hyperparathyroidism at a single institution. J Surg Res 2005; 127(1):58-62.
  77. Shin SH, Holmes H, Bao R, et al. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg 2009; 208(6):1071-6.
  78. Uden P, Chan A, Duh QY, et al. Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg 1992; 16(4):791-7; discussion 798.
  79. Stechman MJ, Weisters M, Gleeson FV, et al. Parathyroidectomy is safe and improves symptoms in elderly patients with PHPT. Clin Endocrinol (Oxf) 2009.
  80. Politz D, Norman J. Hyperparathyroidism in patients over 80: clinical characteristics and their ability to undergo outpatient parathyroidectomy. Thyroid 2007; 17(4):333-9.
  81. Ben Haim M, Zwas ST, Munz Y, et al. Focused, minimally invasive radio-guided parathyroidectomy: a feasible and safe option for elderly patients with primary hyperparathyroidism. Isr Med Assoc J 2003; 5(5):326-8.
  82. Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007; 92(8):3001-5.
  83. Tordjman KM, Greenman Y, Osher E, et al. Characterization of normocalcemic primary hyperparathyroidism. Am J Med 2004; 117(11):861-3.
  84. Bilezikian JP, Potts JT, Jr., Fuleihan Gel H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002; 17 Suppl 2:N2-11.
  85. Lind L, Ljunghall S. Serum urate and renal function in different forms of hypercalcemia. Exp Clin Endocrinol 1992; 99(2):87-90.
  86. Lorentzon R, Larsson HO, Boquist L. Quantitative parathyroid morphology is unaltered in prolonged hypocalcemia. A quantitative electron microscopic study in the Mongolian gerbil. Acta Pathol Microbiol Immunol Scand A 1984; 92(4):267-74.
  87. Gordon W. The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Semin Dial 2004; 17:209-216.
  88. Olson JA, Jr., Leight GS, Jr. Surgical management of secondary hyperparathyroidism. Adv Ren Replace Ther 2002; 9(3):209-18.
  89. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 1991; 15(6):745-50.
  90. Schlosser K, Endres N, Celik I, et al. Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 2007; 31(10):1947-53.

back to Top


Find an Experienced Endocrine Surgeon


Visit Endocrine Patient Resources Page